1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Skin conditions
  5. Psoriasis

Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people

Technology appraisal guidance [TA455] Published: 12 July 2017

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Recommendations
  • 2 The technologies
  • 3 Evidence
  • 4 Committee discussion
  • 5 Implementation
  • 6 Recommendations for research
  • 7 Appraisal committee members and NICE project team
Download guidance (PDF)

Guidance

  • Next

3 Evidence

3 Evidence

The appraisal committee (section 7) considered evidence from a number of sources. See the committee papers for full details of the evidence.

  • National Institute for Health and Care Excellence (NICE)

  • Next